Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

September 2015 Issue of The Ophthalmologist

Register to download

Register here to download any issue of The Ophthalmologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Subspecialties Basic & Translational Research

Exploring Ophthalmology’s Orchard

| Mark Hillen

Across medicine, far fewer clinical trials report positive results these days. Whether the demise of sharp scientific practices or the lack of low-hanging fruit – does it apply to ophthalmology?

Subspecialties Retina

New Kid on the Block

| Michael Schubert

Can amniotic stem cells suppress pathologic retinal neovascularization?

Subspecialties Retina

From Intestine to Eye

| Michael Schubert

Gut microbes may be responsible for activating the T-cells that cause autoimmune uveitis

Subspecialties Retina

The Poor Man’s Aflibercept?

| Michael Schubert

Like bevacizumab before it, ophthalmologists are trying off-label ziv-aflibercept (formulated for systemic use) in the eye. Masterstroke or madness?

Subspecialties Retina

First, Do No Harm

| Mark Hillen

A new study concludes that most surgical procedures used to treat optic disc pits are of no benefit – and may even be harmfu

Subspecialties Retina

Interleukin Forward to a Promising Future in AMD

| Mark Hillen

A novel signaling pathway that leads to choroidal neovascularization has been identified – with obvious therapeutic potential

Subspecialties Retina

Light Years Ahead

| Roisin McGuigan

What if there was an imaging technique that could detect retinal disease processes before any structural damage had even occurred?

Subspecialties Retina

A Novel Avastin Injection Technique

| Murad Sunalp

Direct visualization delivery of bevacizumab in pseudophakic eyes for the treatment of subretinal neovascularization

Subspecialties Retina

Taking the Heat out of Retinal Laser Therapy

| Wilson Heriot

There’s currently an unmet need for effective interventions in early-stage retinal degenerative diseases – before vision is lost. Can three-nanosecond pulse laser therapy meet that need?

Subspecialties Retina

Analyzing the AMD Proteome

| Michael Koss

Looking at vitreous samples allows us to determine which proteins are involved in the disease process, and to what degree

Subspecialties Basic & Translational Research

AMD Clinical Trials

| Mark Hillen, Roisin McGuigan

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.

Subspecialties Basic & Translational Research

AMD – The Modern Marathon

| Tiarnán Keenan

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Subspecialties Professional Development

The Long and Winding Road to VEGF

| Roisin McGuigan

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Subspecialties Retina

Aflibercept in Europe: Setting New Standards in Retinal Disease Care

Strength and durability in the real world

Other issues of 2015